Microneedling: The BEST Needle Size For Hair Regrowth (2024 Update)

Scientific concepts, discoveries, and nature/biological phenomena

Microneedling basics

• Microneedling uses medical-grade needles to create micropunctures in the scalp/skin.
• A proposed hair-loss mechanism involves microwounding, which may:
  • Enhance penetration and activation of topical agents (e.g., minoxidil).
  • Trigger growth factor release and tissue remodeling, potentially supporting hair regrowth and improved cycling.

Why needle length is tricky (device-dependent)

• Rollers and stamps may not reliably reach the intended needle penetration depth because:
  • User pressure variability affects how deep needles enter.
  • Needle entry angle changes during rolling.
• Automated pens are described as better suited to matching the intended depth because needles:
  • Enter more perpendicularly
  • Fire automatically

Skin-layer penetration and expected biological effects

The discussion focuses on different skin layers and what penetrating them may do:

• Epidermis

  • Thickness: ~0.4 mm (average)
  • Limited blood supply
  • Penetration to the epidermis may mainly help topical penetration, but may not produce a strong wound-healing response.

• Dermis

  • Typically 1–2 mm thick
  • Contains microvascular networks
  • Penetrating into the dermis can cause microvascular rupture, leading to localized:
    • Swelling
    • Pinpoint bleeding
  • This may drive a stronger wound healing response.

• Hair follicle stem cell bulges

  • Located approximately 1.0–1.8 mm deep
  • Prior reasoning suggested:
    • Wounding directly above stem cell bulges may be beneficial
    • Wounding into them might worsen timing of healing

Key methodology / study design described (needle-depth trial)

• Journal: Dermatologic Therapy
• Participants: 45 people with androgenic alopecia
• Schedule: microneedling every 2 weeks for 3 months (6 sessions total)
• Device/approach: automated pen microneedling as a standalone therapy (no other treatments)
• Randomization / groups (needle lengths):
  • 0.5 mm
  • 1.0 mm
  • 1.5 mm
• Outcome measures (multiple endpoints):
  • Microscopic hair assessment using a phototrigram device (hair counts/parameters)
  • Macroscopic/cosmetic assessments using standardized photos
  • Clinical evaluations from both:
    • Patients’ perspective
    • Investigators’ perspective
  • Secondary markers:
    • Pain scores
    • Debris reduction around hair shafts
    • Reduction in “yellow dots” (marker of androgenic alopecia activity)

Main findings highlighted

• After 3 months

  • All groups showed some clinical improvement (hair appeared thicker in photos).
  • Best overall hair parameter improvements were reported with the smallest needle length: 0.5 mm
    • Microscopic hair counts showed dramatic improvements.
  • Moderate improvement occurred with 1.0 mm
  • Worst performance—near flatlined results—occurred with 1.5 mm

• Secondary outcomes

  • The 0.5 mm group reported less pain
  • Greater reduction in debris around hair shafts
  • Larger reduction in yellow dots

• Interpretation claim

  • The study suggests smaller needle lengths (in the tested 0.5–1.5 mm automated-pen range) may outperform deeper settings for hair regrowth.

Conclusions / practical claims from the subtitles

Bleeding is likely not necessary

• The study observed pinpoint bleeding, but the host argues that at 0.5 mm it would be sparse/intermittent.
• Practical implication: no—the amount of bleeding people often imagine may not be required for hair gains.
• Instead, redness/pinkness or slight swelling could occur.

“Sweet spot” concept persists

• The subtitles argue earlier recommendations largely still stand:
  • Wounding enough to engage drug penetration + wound healing
  • But not too deep to avoid penetrating the stem cell bulge region
• The discussion also suggests the effective target depth might be wider than before:
  • From ~6–8 mm potentially to ~0.5–8 mm (as interpreted in the summary).

Caution about study limitations

• The highlighted trial is small and has no untreated/placebo control, so results could be influenced by:
  • Natural hair cycling/seasonality
  • Placebo effects
• The host emphasizes that recommendations may change as more evidence accumulates.

Sources / researchers featured (as explicitly named in subtitles)

• Rob English

  • Host; researcher specializing in hair loss disorders
  • Editor on a dermatology journal
  • Author/curator of the prior 2021 systematic literature review

• The summary references:

  • A systematic literature review published in 2021 (host-associated)
  • “A new study” published last month in Dermatologic Therapy
• However, no individual study authors are named for the newer trial in the provided subtitles.